ONO-4538HSC

· Ono Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ONO-4538HSC, covering 2025-07-03 to 2025-07-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of ONO-4538HSC in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]